| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
09-05-2009, 10:55 AM
|
#1 | |||
|
||||
|
In Remembrance
|
Fines unlikely to end off-label drug marketing
Upside is too great for pharmaceutical firms to worry about penalty The Associated Press updated 4:38 p.m. CT, Fri., Sept . 4, 2009 INDIANAPOLIS - Pfizer Inc. was slapped this week with a record $2.3 billion in fines for illegally marketing some drugs, but critics say even that eye-popping total is unlikely to end the sometimes-dangerous practice of promoting drugs for unapproved uses. The penalty pales compared to the billion dollars or more http://www.msnbc.msn.com/id/32694936...s-us_business/ video http://www.msnbc.msn.com/id/31388323...60979#32660979
__________________
with much love, lou_lou . . by . , on Flickr pd documentary - part 2 and 3 . . Resolve to be tender with the young, compassionate with the aged, sympathetic with the striving, and tolerant with the weak and the wrong. Sometime in your life you will have been all of these. |
|||
|
 Reply With Quote
|
|
09-05-2009, 12:12 PM
|
#2 | ||
|
|||
|
Senior Member
|
Okay, now I know I must be really crazy. I'm going to dance to the Blues right now. Don't tell me anything more today unless my house is on fire.
I remember telling people pharma is honest. PD must cause these hallucinations. |
||
|
|
Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Drug companies spend about $19 billion annually on marketing to physicians... | Parkinson's Disease | |||
[BigPharma] -Fines unlikely to end off-label drug marketing
Linear Mode
